DNA Biomed Solns (DNA) — Long-term Investment Intensity
DNA Biomed Solns (DNA) has a Long-term Investment Intensity of 98.7% as of June 2019. Long-term investments of ILA51.99 Million represent 98.7% of total assets of ILA52.70 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check DNA asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
DNA Biomed Solns Long-term Investment Intensity (2013–2018)
This chart shows how DNA Biomed Solns's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of June 2019, the intensity stands at 98.7%, reflecting long-term investments of ILA51.99 Million against total assets of ILA52.70 Million ILA. For the complete balance sheet picture, see how large is DNA Biomed Solns's balance sheet.
Annual Long-term Investment Intensity for DNA Biomed Solns (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for DNA Biomed Solns from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read DNA total debt and obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 99.4% | ILA80.20 Million | ILA80.72 Million | ▲ +1.4 pp |
| 2017 | 97.9% | ILA76.49 Million | ILA78.09 Million | ▲ +81.5 pp |
| 2016 | 16.4% | ILA6.28 Million | ILA38.17 Million | ▼ -6.0 pp |
| 2015 | 22.4% | ILA6.22 Million | ILA27.75 Million | ▼ -11.3 pp |
| 2014 | 33.8% | ILA6.52 Million | ILA19.32 Million | ▲ +6.5 pp |
| 2013 | 27.3% | ILA5.64 Million | ILA20.68 Million | — |